MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells
- PMID: 15598810
- DOI: 10.1182/blood-2004-06-2297
MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells
Abstract
The most frequently recurring translocations in mucosa-associated lymphoid tissue (MALT) B-cell non-Hodgkin lymphoma, t(11;18)(q21;q21) and t(14;18)(q32; q21), lead to formation of an API2-MALT1 fusion or IgH-mediated MALT1 overexpression. Various approaches have implicated these proteins in nuclear factor kappaB (NF-kappa B) signaling, but this has not been shown experimentally in human B cells. Immunohistochemistry showed that MALT1 is predominantly expressed in normal and malignant germinal center B cells, corresponding to the differentiation stage of MALT lymphoma. We expressed MALT1 and apoptosis inhibitor-2 API2/MALT1 in human B-cell lymphoma BJAB cells and found both transgenes in membrane lipid rafts along with endogenous MALT1 and 2 binding partners involved in NF-kappa B signaling, B-cell lymphoma 10 (BCL10) and CARMA1 (caspase recruitment domain [CARD]-containing membrane-associated guanylate kinase [MAGUK] 1). API2-MALT1 and exogenous MALT1 increased constitutive NF-kappa B activity and enhanced I kappa B kinase (IKK) activation induced by CD40 stimulation. Both transgenes protected BJAB cells from FAS (CD95)-induced death, consistent with increases in NF-kappa B cytoprotective target gene expression, and increased their proliferation rate. Expression of a dominant-negative I kappa B alpha mutant showed that these survival and proliferative advantages are dependent on elevated constitutive NF-kappa B activity. Our findings support a model in which NF-kappa B signaling, once activated in a CD40-dependent immune response, is maintained and enhanced through deregulation of MALT1 or formation of an API2-MALT1 fusion.
Similar articles
-
Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma.Apoptosis. 2005 Jan;10(1):25-34. doi: 10.1007/s10495-005-6059-6. Apoptosis. 2005. PMID: 15711920 Review.
-
Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway.J Biol Chem. 2001 Jun 1;276(22):19012-9. doi: 10.1074/jbc.M009984200. Epub 2001 Mar 21. J Biol Chem. 2001. PMID: 11262391
-
A Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-kappaB activation by API2middle dotMALT1 fusions.J Biol Chem. 2007 Apr 6;282(14):10180-9. doi: 10.1074/jbc.M611038200. Epub 2007 Feb 7. J Biol Chem. 2007. PMID: 17287209
-
Selective expansion of marginal zone B cells in Emicro-API2-MALT1 mice is linked to enhanced IkappaB kinase gamma polyubiquitination.Cancer Res. 2006 May 15;66(10):5270-7. doi: 10.1158/0008-5472.CAN-05-4590. Cancer Res. 2006. PMID: 16707452
-
Molecular pathogenesis of MALT lymphoma: two signaling pathways underlying the antiapoptotic effect of API2-MALT1 fusion protein.Leukemia. 2006 Jun;20(6):929-36. doi: 10.1038/sj.leu.2404192. Leukemia. 2006. PMID: 16572204 Review.
Cited by
-
Eugenol inhibits cell proliferation via NF-κB suppression in a rat model of gastric carcinogenesis induced by MNNG.Invest New Drugs. 2011 Feb;29(1):110-7. doi: 10.1007/s10637-009-9345-2. Epub 2009 Oct 23. Invest New Drugs. 2011. PMID: 19851710
-
Human dendritic cells exhibit a pronounced type I IFN signature following Leishmania major infection that is required for IL-12 induction.J Immunol. 2014 Jun 15;192(12):5863-72. doi: 10.4049/jimmunol.1203230. Epub 2014 May 7. J Immunol. 2014. PMID: 24808365 Free PMC article.
-
Delving deeper into MALT lymphoma biology.J Clin Invest. 2006 Jan;116(1):22-6. doi: 10.1172/JCI27476. J Clin Invest. 2006. PMID: 16395399 Free PMC article.
-
CD47 overexpression is common in intestinal non-GCB type diffuse large B-cell lymphoma and associated with 18q21 gain.Blood Adv. 2022 Dec 27;6(24):6120-6130. doi: 10.1182/bloodadvances.2021006305. Blood Adv. 2022. PMID: 35475881 Free PMC article.
-
Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk.PLoS One. 2009;4(4):e5360. doi: 10.1371/journal.pone.0005360. Epub 2009 Apr 24. PLoS One. 2009. PMID: 19390683 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous